Skycity Entertainment Group Ltd (SKC)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 0.545 |
|---|---|
| 52-week range | 0.380 – 0.863 |
| Return, 1 month / 3 months | +5.8% / −0.9% |
| Return, 1 year / 3 years | −16.8% / −68.9% |
| Trend | Below its 200-day average |
| RSI (14) | 53 |
| Volatility (1 year) | 44.5% |
| Worst drawdown (1 year) | -55.3% |
| Average daily value traded | 0.13M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SkyCity Entertainment Group operates casinos and entertainment complexes, chiefly in New Zealand. Its flagship precinct in Auckland combines a gaming floor with hotels, restaurants, bars and conference facilities, and the company runs similar properties in other New Zealand centres as well as in Adelaide, Australia. It serves leisure visitors, conference and event organisers, diners and hotel guests, and is based in Auckland.
The shares are listed on the Australian Securities Exchange in Australia under the code SKC, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Skycity Entertainment Group Ltd (SKC) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.545 on 19 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 657 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.8% and over the last three months it fell 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.0% | ||
| From 52-week high | -35.9% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.9% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | -21.4% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -55.3% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.13M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | +5.8% |
| 3 months | −0.9% |
| 6 months | +0.0% |
| 1 year | −16.8% |
| 3 years | −68.9% |
| 5 years | −80.5% |
Signals
| 50-day / 200-day average | 0.534 / 0.568 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.018 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Mar 2024 | NZD 0.0455 |
| 7 Sep 2023 | NZD 0.0514 |
| 2 Mar 2023 | NZD 0.0517 |
| 16 Sep 2021 | NZD 0.0629 |
| 27 Feb 2020 | NZD 0.0893 |
| 29 Aug 2019 | NZD 0.0887 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.